All lobbying filings
Capitol 6 Advisors
Capitol 6 Advisors filed a Q3 report for Amgen on October 19, 2026, reporting no lobbying activity.
Lobbying for Amgen · Biopharmaceutical company
Filing · LD-2 quarterly report
Q3 reportNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
0
No itemized activity in this filing.